Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-05-17 00:00:00 ET · period of report 2022-05-13 · accession 0001567619-22-011119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-17 | 2022-05-13 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | P - Purchase | $40.49 | +158 | 97.5K | +0.2% | +$6,397 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-05-13 | P | A | 158 | $40.49 | 97,523 | D | — | — |